Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Drug maker swap test: are these pills truly twins?

NCT ID NCT06360081

Summary

This study tested if a zongertinib tablet made by one company works the same in the body as a tablet made by another company. It involved 56 healthy adults who each took a single dose of both versions. Researchers measured drug levels in the blood to see if the two tablets are bioequivalent, meaning they deliver the drug to the body in the same way.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CRS Clinical Research Services Mannheim GmbH

    Mannheim, 68167, Germany

Conditions

Explore the condition pages connected to this study.